Browse > Article

Factors Associated with Overweight and Obesity in Inpatients with Bipolar Mania : A Preliminary Study  

Jung, Young-Eun (Department of Psychiatry, College of Medicine The Catholic University of Korea)
Seo, Ho-Jun (Department of Psychiatry, College of Medicine The Catholic University of Korea)
Song, Hoo-Rim (Department of Psychiatry, College of Medicine The Catholic University of Korea)
Wang, Hee-Ryung (Department of Psychiatry, College of Medicine The Catholic University of Korea)
Jun, Tae-Youn (Department of Psychiatry, College of Medicine The Catholic University of Korea)
Bahk, Won-Myong (Department of Psychiatry, College of Medicine The Catholic University of Korea)
Publication Information
Anxiety and mood / v.6, no.2, 2010 , pp. 109-114 More about this Journal
Abstract
Objective : Being overweight or obesity impairs quality of life and often causes treatment noncompliance in patients with bipolar disorder. This preliminary study evaluated the prevalence of overweight and obesity in inpatients with bipolar mania. Methods : Inpatients with bipolar mania, who were treated with adequate medications at least 4 weeks were included in a retrospective study. The body weight of each patient was measured and the body mass index (BMI) was calculated. Results : Of the 80 patients, 16.4% (N=13) were overweight, and 35.0% (N=28) were obese at discharge. Female patients had higher prevalence rates of overweight and obesity. Being overweight or obesity was associated with the number of previous episodes of depression and combination treatment with atypical antipsychotics and mood stabilizers. Conclusions : Being overweight or obesity is highly prevalent in patients with bipolar mania. Clinicians should pay more attention to weight gain and obesity when prescribing combination therapies. More research is required to identify the impact of specific risk factors for overweight and obesity in patients with bipolar mania.
Keywords
Bipolar mania; Overweight; Obesity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Haslam DW, James WP. Obesity. Lancet 2005;366:1197-1209.   DOI   ScienceOn
2 Kruger S, Shugar G, Cooke RG. Comorbidity of binge eating disorder and the partial binge eating syndrome with bipolar disorder. Int J Eat Disord 1996;19:45-52.   DOI   ScienceOn
3 McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PE Jr, Leverich GS, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207-213.   DOI   ScienceOn
4 Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003; 160:1263-1271.   DOI   ScienceOn
5 Reynolds GP, Zhang ZJ, Zhang XB. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 2002;359:2086-2087.   DOI   ScienceOn
6 Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481-489.   DOI
7 Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004;27:596-601.   DOI   ScienceOn
8 Marken PA, Pies RW. Emerging treatments for bipolar disorder: safety and adverse effect profiles. Ann Pharmacother 2006;40:276-285.   DOI   ScienceOn
9 Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005;162:1281-1290.   DOI   ScienceOn
10 Kim B, Kim SJ, Son JI, Joo YH. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients. J Affect Disord 2008;105:45-52.   DOI   ScienceOn
11 Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav 2009;97:199-204.   DOI   ScienceOn
12 Phillips GB, Jing T, Heymsfield SB. Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women. Metabolism 2008;57:838-844.   DOI   ScienceOn
13 Stedman T, Welham J. The distribution of adipose tissue in female patients receiving psychotropic drugs. Br J Psychiatry 1993;162:249-250.   DOI   ScienceOn
14 Silverstone T, Smith G, Goodall E. Prevalence of obesity in patients receiving depot antipsychotics. Br J Psychiatry 1988;153:214-217.   DOI   ScienceOn
15 Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999;60:215-220.   DOI   ScienceOn
16 Vestergaard P, Poulstrup M, Schou M. Prospective studies in a lithium cohort, 3: tremor, weight gain, diarrhea, psychological complaints. Acta Psychiatr Scand 1988;78:434-441.   DOI   ScienceOn
17 Fava M. Weight gain and antidepressants. J Clin Psychiatry 2000;61 (suppl 11):37-41.
18 Vornik LA, Brown ES. Management of comorbid bipolar disorder and substance abuse. J Clin Psychiatry 2006;67(Suppl 7):24-30.
19 Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004;61:1107-1115.   DOI   ScienceOn
20 Taylor V, Macqueen G. Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry 2006;67:1034-1041.   DOI   ScienceOn
21 Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 1999;60:358-363.   DOI
22 Nemeroff CB. Safety of available agents used to treat bipolar disorder: focus on weight gain. J Clin Psychiatry 2003;64:532-539.   DOI   ScienceOn
23 American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorder 4th ed. Washington DC, American Psychiatric Press; 1994.
24 Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. World Rev Nutr Diet 2005;94:1-12.
25 Kurzthaler I, Fleischhacker WW. The clinical implications of weight gain in schizophrenia. J Clin Psychiatry 2001;62(suppl 7):32-37.
26 Kim DM, Ahn CW, Nam SY. Prevalence of obesity in Korea. Obes Rev 2005;6:117-121.   DOI   ScienceOn
27 Elmslie JL, Silverstone JT, Mann JI, Williams SM, Romans SE. Prevalence of over weight and obesity in bipolar patients. J Clin Psychiatry 2000;61:179-184.   DOI   ScienceOn
28 Rosenbaum M, Leibel RL, Hirsch J. Medical progress: obesity. N Engl J Med 1997;337:396-407.   DOI   ScienceOn
29 Keck PE, McElroy SL. Bipolar disorder, obesity, and pharmacotherapy- associated weight gain. J Clin Psychiatry 2003;64:1426-1435.   DOI   ScienceOn
30 Malhotra S, McElroy SL. Associations between metabolic syndrome and psychiatric disorder. Prim Psychiatry 2003;10:37-44.
31 Fagiolini A, Frank E, Houck PR, Mallinger A, Swartz H, Buysse DJ, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002;63:528-534.   DOI   ScienceOn
32 Behn A, Ur E. The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol 2006;21:353-360.   DOI   ScienceOn
33 Elmslie JL, Mann JI, Silverstone JT, Williams SM, Romans SE. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001;62:486-491.   DOI   ScienceOn
34 Ramacciotti CE, Paoli RA, Marcacci G, Piccinni A, Burgalassi A, Dell'Osso L, et al. Relationship between bipolar illness and bingeeating disorders. Psychiatry Res 2005;135:165-170.   DOI   ScienceOn
35 James PT, Leach R, Kalamara E, Shayeghi M. The Worldwide Obesity. Epidemic Obes Res 2001;9:228-233.   DOI